Atlas market file · Equity · United States
Camtek LtdCAMT
- Last close
- 149.67
- Change
- +1.40%
- 96-bar range
- 126.34 – 215.99
- As of
- 6 Aug 2026
Camtek Ltd is an optical instruments & lenses issuer listed as CAMT on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+52.77% over the window).
Source rail: Yahoo Finance chart API (CAMT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CAMT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CAMT public profile
Optical instruments & lenses issuer. Camtek Ltd is connected to current market context, cited company sources and its retained research file.
Camtek Ltd trades as CAMT on NASDAQ. Camtek Ltd (CAMT) has a latest verified close of 149.67, up 1.40%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CAMT under USA Stocks for browsing.
What changed for Camtek Ltd today
Camtek Ltd, the Israeli maker of semiconductor inspection and metrology tools, filed a Schedule 13G/A on 23 July 2026 that quietly confirmed Harel Insurance had signed off on the company’s integrated audit for the year ending 31 December 2025. The filing itself is routine-until you recall that Camtek posted $496.1 million in revenue, $50.7 million in net income, and $141.9 million in operating cash flow for that year. In other words, a company capable of generating half a billion dollars still needs an external auditor to complete its filing trail. The gap between the platform story and the filing receipts is the first clue that Camtek’s narrative is running on more ambition than operating leverage.
Camtek’s Hawk system is the marquee product in its portfolio, marketed as the answer to advanced packaging inspection for Chiplets, HBM, and Hybrid Bonding-three buzzwords that have turned analysts’ heads and loosened procurement budgets across the OSAT universe. The company’s own 6-K dated 2 June 2026 announced a multi-system order worth $55 million from a single tier-1 OSAT, plus additional orders exceeding $50 million for Hawk systems. That’s a neat concentration of revenue: two chunks of work, one customer cluster, and the rest of the world left to wonder whether the orders are repeatable or one-off bonanzas. Camtek’s product pages and image library do the rest of the selling, but the filings are the ones that collect the cash.
Pull the filings apart and the numbers tell a different story. In the 20-F for the year ending 31 December 2025, Camtek reported revenue of $496.1 million, net income attributable to parent of $50.7 million, operating income of $128.2 million, and diluted EPS of $1.04 on a diluted share count of 49,970. Cash and equivalents stood at $177.8 million, while liabilities totalled $642.8 million and stockholders’ equity was $617.0 million. Operating cash flow clocked in at $141.9 million, capex was $14.4 million, R&D expense was $48.3 million, and inventory grew by $8.3 million to $112.2 million. The math is internally consistent, but the optics are unforgiving: a company with half-a-billion in revenue still carries liabilities that exceed equity and inventory that keeps climbing.
The tension is visible on the product pages. Camtek’s Eagle platform handles macro inspection at full production rate, while the Hawk system is positioned for advanced packaging markets. The image library shows gleaming machines in cleanrooms, but the filings reveal a company that has not yet translated product leadership into balance-sheet leverage. The company’s site lists inspection and metrology tools as core offerings, yet the single largest documented order in the 6-K is a $55 million multi-system deal-large by any standard, concentrated by necessity. The rest of the catalogue reads like a wish list until the next order arrives.
For readers chasing narrative rather than noise, the chart route is straightforward: Camtek trades on the Tel Aviv Stock Exchange under ticker CAMT and files with the SEC as a foreign private issuer. The company’s SEC submissions JSON and companyfacts JSON are the canonical rails for granular XBRL data, while the product pages and press rails confirm the Hawk and Eagle positioning. The SEC EDGAR filing index links every disclosure, including the recent 13G/A and 6-Ks, so anyone can trace the gap between polished brochures and filed receipts. No one needs to guess what’s real; the filings are there, and they speak plainly.
What remains unproven is whether Camtek can diversify away from single-customer concentration without repeating the $55 million headline. The 20-F does not provide segment-level revenue splits, so the source requires readers to infer that the majority of growth rides on advanced packaging demand and a handful of marquee customers. The inventory build also raises questions: is Camtek stockpiling for future orders or signalling demand softness that the glossy press kit won’t admit? Until the next 6-K or 10-K breaks out customer concentration and segment performance, the file will stay lean on hard data and heavy on marketing.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CAMT technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CAMT
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CAMT research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CAMT FAQ
What is Camtek Ltd (CAMT)?Camtek Ltd (CAMT) has a latest verified close of 149.67, up 1.40%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Camtek Ltd (CAMT) has a latest verified close of 149.67, up 1.40%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CAMT?Camtek Ltd (CAMT) has a latest verified close of 149.67, up 1.40%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the...
Camtek Ltd (CAMT) has a latest verified close of 149.67, up 1.40%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CAMT under USA Stocks for browsing.
How often is the CAMT page updated?The CAMT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CAMT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CAMT?The CAMT file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CAMT. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The CAMT file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CAMT. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CAMT?Yes. The workstation can open CAMT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CAMT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CAMT page investment advice?No. The CAMT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CAMT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CAMT
Equity · evidence first